Semanteon Capital Management, LP Neogenomics Inc Transaction History
Semanteon Capital Management, LP
- $141 Billion
- Q2 2024
A detailed history of Semanteon Capital Management, LP transactions in Neogenomics Inc stock. As of the latest transaction made, Semanteon Capital Management, LP holds 68,920 shares of NEO stock, worth $973,150. This represents 0.68% of its overall portfolio holdings.
Number of Shares
68,920
Previous 20,107
242.77%
Holding current value
$973,150
Previous $316 Million
202.43%
% of portfolio
0.68%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
279Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$278 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$199 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$124 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$95 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$93.5 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.78B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...